Lepu Biopharma Co., Ltd. (HKG:2157)

Lepu Biopharma Revenue

Lepu Biopharma had revenue of 465.94M CNY in the half year ending June 30, 2025, with 203.44% growth. This brings the company's revenue in the last twelve months to 700.45M, up 241.55% year-over-year. In the year 2024, Lepu Biopharma had annual revenue of 367.79M with 63.21% growth.

• Revenue (ttm): 700.45M CNY
• Revenue Growth: +241.55%
• P/S Ratio: 10.84
• Revenue / Employee: 1.28M CNY
• Employees: 546
• Market Cap: 8.32B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	367.79M	142.44M	63.21%
Dec 31, 2023	225.35M	209.78M	1,347.16%
Dec 31, 2022	15.57M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-